Immunotherapy of Neuroblastoma with CAR.GD2 NKT Cells |
Baylor College of Medicine / Leonid S. Metelitsa, M.D., Ph.D. |
Bio-Therapeutic Impact Award |
2014 |
Texas |
Elucidating the Mechanism of ERK Mediated Pathogenesis of LCH |
Baylor College of Medicine / Rikhia Chakraborty, PhD |
Young Investigator Grants |
2015 |
Texas |
Enhancing the Viability, Function, and Safety, of Genetically-Enhanced NK Cells Within the Solid Tumor Microenvironment With IL-15 and a Suicide Gene |
Baylor College of Medicine / Robin Parihar, MD, PhD |
Young Investigator Grants |
2015 |
Texas |
Genetically Engineered T Cells as Therapy for Pediatric Glioma |
Baylor College of Medicine / Giedre Krenciute, PhD |
Young Investigator Grants |
2016 |
Texas |
Interrogating the Enhancer Landscapes of Ependymoma to Inform Novel Therapies |
Baylor College of Medicine / Stephen Mack, PhD |
Young Investigator Grants |
2016 |
Texas |
Targeting MYCN-amplified Neuroblastoma Through RORalpha Activation |
Baylor College of Medicine / Eveline Barbiere, MD |
Innovation Grants |
2016 |
Texas |
Engineering the CAR T Cells to Overcome Tumor Derived Immune-Inhibition in Glioblastoma |
Baylor College of Medicine / Meenakshi Hegde, MD |
'A' Award Grants |
2016 |
Texas |
Natural Killer T cells with an IL-15-armored GD2-specific CAR for Children with Neuroblastoma |
Baylor College of Medicine / Andras Heczey, MD |
Bio-Therapeutic Impact Award |
2017 |
Texas |
Modeling and Therapeutic Targeting of p21-Activated Kinase Members in High-Risk Rhabdomyosarcoma |
Baylor College of Medicine / Jason Yustein, MD/PhD |
Innovation Grants |
2018 |
Texas |
Functional Characterization of RELA Fusion Ependymoma as a Basis for Therapeutic Targeting |
Baylor College of Medicine / Stephen Mack, PhD |
'A' Award Grants |
2018 |
Texas |